This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International
Delivered as a Hybrid Event
September 27-30, 2022Boston Convention and Exhibition Center

Mark Duerkop
Chief Executive Officer at Novasign

Profile

Dr. Mark Duerkop is co-founder and CEO of Novasign GmbH a spin-off from the University of Natural Resources and Life Sciences in Vienna focusing on accelerating bioprocess development by application of advanced machine learning tools. Within the last years Mark developed a hybrid modeling software with his team that help bioprocess engineers to better understand their processes while additionally reducing the experimental effort to find process optima.

Agenda Sessions

  • Chairperson's Opening Remarks

    12:55pm
  • Digital-Twin assisted acceleration of bioprocess development. Hurdles and Solution pathways

    1:00pm